Citius Pharma(CTXR.US)

Last Updated 19:00:00 ET
longbridge loading

12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga_article·
US
GOSS
-9.89%
US
LTRN
+8.52%
US
AIM
-5.29%
benzinga_article·
US
GOSS
-9.89%
US
LTRN
+8.52%
US
AIM
-5.29%

16:30 ETCitius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

prnewswire·
US
CTXR
+13.90%
US
PBE
+0.33%
US
BBH
+0.85%
prnewswire·
US
CTXR
+13.90%
US
PBE
+0.33%
US
BBH
+0.85%

Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update | CTOR Stock News

StockTitan·
US
CTOR
-0.67%
StockTitan·
US
CTOR
-0.67%

Citius Pharmaceuticals Amends Promissory Note to Enhance Flexibility

Tip Ranks·
US
CTXR
+13.90%
US
CTOR
-0.67%
US
LABU
+2.80%
Tip Ranks·
US
CTXR
+13.90%
US
CTOR
-0.67%
US
LABU
+2.80%

Citius raises $36.5m for Lymphir commercialisation

Pharmaceutical Technology·
US
CTXR
+13.90%
Pharmaceutical Technology·
US
CTXR
+13.90%

Citius Pharmaceuticals Raises ~$5M; Issues Warrants in Registered Direct and Private Placement

TradingView·
US
CTXR
+13.90%
US
XBI
+0.96%
US
SBIO
+1.98%
TradingView·
US
CTXR
+13.90%
US
XBI
+0.96%
US
SBIO
+1.98%

Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules | CTXR Stock News

StockTitan·
US
CTXR
+13.90%
StockTitan·
US
CTXR
+13.90%
© 2026 Longbridge｜Disclaimer